Abstract
To investigate the status of GCs use as systemic medication in Guizhou Province, China and evaluate the effectiveness of current management interventions for GCs. The study was based on the Quality Control Center of Guizhou Pharmacy Administration and conducted by sending questionnaires to the member hospitals within Guizhou Province. Chi-square test and analysis of variance were used in univariate analysis, while logistic regression and multiple linear regression were applied in multivariate analysis. This survey included 271 hospitals in Guizhou Province. The average number of prescriptions on systemic use of GCs was 2.18 [95%CI (credible interval: 1.83-2.59)] per 100 outpatients prescriptions, with an average dose of 10.19 (95%CI: 8.50-12.21) mg per visit (calculated by hydrocortisone) in 2018. Fifty-one hospitals (18.82%), especially in Grass-roots Healthcare Centers (GHC) (34/51), considered fever and pain caused by common infections as the main indication for systemic administration of GCs. Multivariate analyses suggested that current management interventions for GCs had little effect on the rational use of GCs (P＞0.05). The status of irrational use of GCs in Guizhou Province is alerting, especially in GHC. It is necessary to restrict the indication for GCs use and improve the management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
